MedPath

A study on siddha trail drug Kurunthotti Kashayam (Int) Azhinjil Thylam (Ext) and Varmam in patients having neck pain

Phase 2
Recruiting
Conditions
Saganavatham (Cervical spondylosis)
Registration Number
CTRI/2018/02/011686
Lead Sponsor
Government Siddha Medical College
Brief Summary

This is an open clinical study to evaluate the efficacy of Kurunthotti Kashayam (Internal) and Azhinjil Thylam (External). 60 ml of Kurunthotti kashayam and sufficient quantity of Azhinjil Thylam will be given for 48 days. Varmam therapy is given for all the patients.Sample size is 60. The trial drugs Kurunthotti Kashayam and Azhinjil Thylam contain some active herbs having anti inflammatory and analgesic properties which will be helpful to cure Cervical spondylosis

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Pain in the nape of the neck 2.
  • Radiating pain to the upper limbs up to the tip of the fingers with or without numbness in the upper limbs 3.
  • Giddiness 4.
  • Neck stiffness.
Exclusion Criteria
  • History of 1.Trauma.
  • Thoracic outlet syndrome.
  • Cervical IVDP.
  • Congenital anomalies of spine like Torticolis, Spina bifida & scoliosis.
  • Sero Negative Spondylarthropathy like Ankylosing spondylitis, Polyarthritis etc… 6.
  • Syringomyelia.
  • Tuberculosis of spine 8.
  • Neuropathic arthropathy in Diabetes mellitus 9.
  • Cardiac diseases 10.
  • Neoplasms 11.
  • Pregnancy & Lactation 12.
  • Patients with any other serious systemic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is reduction of pain in neck which is assessed by Visual analog scalenil
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Arignar Anna Hospital of Indian Medicine

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Dr R Rasakumar
Principal investigator
9843172369
rasakumar29@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.